Title
A Phase II Trial of TECLISTAMAB in patients with previously treated Light-Chain (AL) AmyloidosisStudy map
Overview / Summary
In this trial, we aim to evaluate the efficacy and safety of teclistamab in relapsed/refractory AL patients with AL Amyloidosis.
Study details
Patient eligibility criteria
Publications
No publications connected to this trial at the moment
